Reduction of postischemic brain damage and memory deficits following treatment with the selective adenosine A 1 receptor agonist

By Von Lubitz D.K.J.E.   Beenhakker M.   Lin R.C.-S.   Carter M.F.   Paul I.A.   Bischofberger N.   Jacobson K.A.  

European Journal of Pharmacology, Vol. 302, Iss. 1, 1996-04 ,pp. : 43-48

Elsevier

Access to resources Recommend Favorite

Intravenous AMP 579, a novel adenosine A 1 /A 2a receptor agonist, induces a delayed protection against myocardial infarction in minipig

By Meng H.   McVey M.   Perrone M.   Clark K.L.  

European Journal of Pharmacology, Vol. 387, Iss. 1, 2000-11 ,pp. : 101-105

Elsevier

Access to resources Recommend Favorite

Differential effects of selective adenosine A 1 and A 2A receptor agonists on dopamine receptor agonist-induced behavioural responses in rats

By Rimondini R.   Ferre S.   Gimenez-Llort L.   Ogren S.O.   Fuxe K.  

European Journal of Pharmacology, Vol. 347, Iss. 2, 1998-04 ,pp. : 153-158

Elsevier

Access to resources Recommend Favorite

New potent and selective human adenosine A 3 receptor antagonists

By Baraldi P.G.   Borea P.A.  

Trends in Pharmacological Sciences, Vol. 21, Iss. 12, 2000-12 ,pp. : 456-459

Elsevier

Access to resources Recommend Favorite

New Highly Potent and Selective Adenosine A3 Receptor Antagonists

By  

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 8, 2004-04 ,pp. : 863-870

Bentham Science Publishers

Access to resources Recommend Favorite